Back to Search
KRISTY THURSTON, M.D.
M.D.
Colon & Rectal Surgery Physician
NPI: 1396915153IndividualAccepts Medicare
Specialties, Licenses & Credentials
Colon & Rectal Surgery PhysicianPrimary
Colon & Rectal Surgery
Code: 208C00000X
051838(CT)
Surgery Physician
Surgery
Code: 208600000X
051838(CT)
CMS Specialties
PrimaryCOLORECTAL SURGERY (PROCTOLOGY)
Additional
GENERAL SURGERY
Education
UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Class of 2007
Research & Publications (14)
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
PMID 18349311·Radiology·2008
8-other
Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
PMID 16990462·J Vasc Interv Radiol·2006
6-review
Chemical modification of SWNT alters in vitro cell-SWNT interactions.
PMID 16315191·J Biomed Mater Res A·2006
7-preclinical
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
PMID 16923973·J Vasc Interv Radiol·2006
6-review
Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
PMID 17056999·J Vasc Interv Radiol·2006
6-review
Angiographic considerations in patients undergoing liver-directed therapy.
PMID 16002500·J Vasc Interv Radiol·2005
6-review
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
PMID 16371530·J Vasc Interv Radiol·2005
3-trial
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
PMID 16371529·J Vasc Interv Radiol·2005
3-trial
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.
PMID 15713921·J Vasc Interv Radiol·2005
3-trial
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
PMID 15713920·J Vasc Interv Radiol·2005
3-trial
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
PMID 15508085·Gastroenterology·2004
4-observational
Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
PMID 15064336·J Vasc Interv Radiol·2004
8-other
Melatonin and locomotor activity in the fiddler crab Uca pugilator.
PMID 12911115·J Exp Zool A Comp Exp Biol·2003
7-preclinical
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer.
PMID 12354840·J Vasc Interv Radiol·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 85 SEYMOUR ST, STE 425
HARTFORD, CT 06106 - Phone
- (860) 548-7336
Quick Facts
- NPI
- 1396915153
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 14
Are you this provider?
Claim Your Profile